Home Equities Score SCYNEXIS, Inc. (SCYX) stock falling in Pre-Market today: What’s the story behind...

SCYNEXIS, Inc. (SCYX) stock falling in Pre-Market today: What’s the story behind it?

Shares of the SCYNEXIS, Inc. (SCYX) stock were falling in the pre-market today on June 3, 2021, after suffering a huge drop of 15.25% at the previous closing. SCYX stock price saw a downtrend of 4.97% to drop at $8.03 a share as of this writing. There seems to be no news related to SCYX stock in today’s date however, SCYNEXIS announced FDA approval for BREXAFEMME® yesterday. Let’s discuss SCYX stock in depth.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

FDA approval for BREXAFEMME:

BREXAFEMME is ibrexafungerp tablets used to treat adult and postmenarchal pediatric females suffering from vulvovaginal candidiasis (VVC), formally known as a vaginal yeast infection. SCYX stock has received the U.S Food and Drug approval for BREXAFEMME which is the first approved oral non-azole treatment for VVC. The positive results and highest efficacy of BREXAFEMME noticed in phase 3 studies resulted the FDA approval for the frug. For the commercial launch of BREXAFEMME in the U.S, which is expected in the second half of the year, SCYX stock has signed a partnership agreement with Amplity Health.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

First Quarter 2021 Financial Results:

About two weeks ago, SCYX stock on May 17, 2021, did announce the first quarter 2021 financial results the highlights of which are given below.

  • SCYNEXIS reported a net loss of $4.7 million or $0.18 per basic and $0.23 per diluted share in the first quarter of 2021 which is lower as compared to $7.0 million, or $0.72 per basic and diluted share net loss in the same quarter of last year.
  • SCYX stock spent $6.9 million in the research and development expenses in the first three months of 2021 while these expenses were much higher in the same period of the prior year.
  • SCYX stock reported selling, general and administrative expenses of $6.7 million for the first quarter of 2021, much higher than $2.6 million in the same period of the year before.
  • Other expenses for the SCYX stock totaled $2.0 million in the recently reported quarter as compared to $5.5 million total other income in the prior year same period.

Balance Sheet:

As of March 31, 2021, SCYX stock had cash and cash equivalents of $92.0 million which represents a decrease of $1.0 million as compared to cash and cash equivalents by the end of December 2020.

Corporate Developments:

In the first three months of 2021, SCYX stock signed many agreements which include licensing and strategic partnership agreement with Hansoh Pharmaceutical, partnership with Amplity health for the commercialization of  BREXAFEMME, third party agreement for the selling of 2020 New Jersey NOLs, and signing of $60 million loan agreement with Silicon Valley Bank and Hercules Capital, Inc.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Conclusion:

SCYX stock is gloomy despite recent news of FDA approval for BREXAFEMME®. SCYNEXIS management is looking forward to advancing the ibrexafungerp pipeline by building an antifungal franchise in order to create an impact in the future.

 

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

Roblox Corp. (NASDAQ: RBLX) stock falls during pre-market trading session. What’s happening?

Roblox Corp. (NASDAQ: RBLX) stock gained by 2.28% at last close while the RBLX stock price declines by 8.13% in the pre-market trading session....

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Aprea Therapeutics Inc. (APRE) stock soars during current market trading. What’s the update?

Aprea Therapeutics Inc. (NASDAQ: APRE) stock gained by 41.03% at the last check in the current market trading. Aprea Therapeutics is a pharmaceutical business...

TAL Education Group (TAL) stock is tumbling today: What’s Going on?

Shares of the TAL Education Group (TAL) stock were tumbling in the current market trading session today on June 16, 2021, without any obvious...

SPI Energy Inc. (SPI) stock surged in the current market trading. Here’s the update

SPI Energy Inc. (NASDAQ: SPI) stock soars by 15.42% during the current market trading session. SPI Energy is an international renewable energy company that...

Related News

Ocugen Inc. (OCGN) stock surged during pre-market trading session. Here’s what you should know?

Ocugen Inc. (NASDAQ: OCGN) stock gained by 2.12% at last close while the OCGN stock price soars during pre-market trading by 4.95%. Ocugen, Inc....

Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?

Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%....

Unique Fabricating Inc. (UFAB) stock gains during pre-market trading. Let’s figure out why?

Unique Fabricating Inc. (NASDAQ: UFAB) stock declined by 1.21% at the last close while the UFAB stock price tends to rise by 40.67% in...

Torchlight Energy Resources Inc. (TRCH) stock soars during after-hour session. Let’s see why?

Torchlight Energy Resources Inc. (NASDAQ: TRCH) stock gained by 14.74% at last close while the TRCH stock price further rose by 16.48% in the...

Orphazyme A/S (ORPH) stock is Popping High in Pre-Market today: Here’s to know Why?

Shares of Orphazyme A/S (ORPH) stock were popping high in the pre-market today on June 14, 2021, after dropping with more than half of...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam